Failure of glucagon to induce hepatic phosphoenolpyruvate carboxykinase in endotoxic shock

R D Stith1, R E McCallum

  • 1Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City 73190.

Circulatory Shock
|November 1, 1988
PubMed

Insights

Endotoxemia inhibits glucagon

Area of Science:

  • Biochemistry
  • Endocrinology
  • Molecular Biology

Background:

  • Glucocorticoids and glucagon cooperatively regulate phosphoenolpyruvate carboxykinase (PEPCK) mRNA expression.
  • Endotoxemia is known to diminish PEPCK activity, partly due to inhibited glucocorticoid action.
  • The effect of endotoxin on glucagon's induction of PEPCK remains unclear.

Purpose of the Study:

  • To investigate whether endotoxin inhibits glucagon's action to induce hepatic PEPCK activity.

Main Methods:

  • Mice were fasted and treated with endotoxin or saline.
  • Animals received glucose and ad libitum access to food and water.
  • Intravenous glucagon was administered, followed by analysis of plasma glucose and liver PEPCK activity.

Main Results:

  • In control mice, glucagon increased plasma glucose and hepatic PEPCK activity.
  • In endotoxin-treated mice, glucagon failed to increase plasma glucose or PEPCK activity.
  • Endotoxin significantly inhibited glucagon's ability to raise plasma glucose and PEPCK levels.

Conclusions:

  • Glucagon's action to stimulate PEPCK activity and plasma glucose is inhibited during endotoxemia.
  • This finding highlights a mechanism by which endotoxemia disrupts glucose homeostasis.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Acute Pancreatitis II: Pathophysiology01:21

Acute Pancreatitis II: Pathophysiology

The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...